Not available
Quote | IRIDEX Corporation (NASDAQ:IRIX)
Last: | $2.87 |
---|---|
Change Percent: | -2.03% |
Open: | $3.0201 |
Close: | $2.87 |
High: | $3.0201 |
Low: | $2.82 |
Volume: | 52,286 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
News | IRIDEX Corporation (NASDAQ:IRIX)
2024-03-28 19:12:12 ET Summary Iridex Corporation is undergoing a strategic review process to unlock shareholder value. The company is likely to sell its retina business line and potentially parse it out in more than one transaction "soon." The glaucoma business line is highly...
2024-03-26 19:30:17 ET IRIDEX Corporation (IRIX) Q4 2023 Results Conference Call March 26, 2024 05:00 PM ET Company Participants Philip Taylor - IR David Bruce - CEO Fuad Ahmad - Interim CFO Conference Call Participants Tom Stephan - Stifel Pres...
Message Board Posts | IRIDEX Corporation (NASDAQ:IRIX)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $IRIX News Article - Iridex Announces Preliminary Operational and Financial Results for | whytestocks | investorshangout | 01/10/2023 9:15:54 PM |
lortscherunser: WHSI Readying New Websites, Dealer Academy In Remote Monitoring Market https://capit | lortscherunser | investorshangout | 03/14/2022 11:19:47 AM |
whytestocks: $IRIX News Article - Iridex to Present at the Lytham Partners Fall 2021 Investor Confer | whytestocks | investorshangout | 09/30/2021 8:30:49 PM |
whytestocks: $IRIX News Article - Scoop Up These 2 'Strong Buy' Healthcare Stocks Trading More Than | whytestocks | investorshangout | 09/24/2021 3:30:48 PM |
Does seem like a buyout! | Sage7243 | investorshub | 03/02/2021 9:42:12 PM |
News, Short Squeeze, Breakout and More Instantly...
MOUNTAIN VIEW, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial resul...
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...